CMS Pub. 100-04, ch. 13, § 60.10

For services furnished on or after October 1, 2003, Medicare covers the use of FDG PET

for thyroid cancer only for restaging of recurrent or residual thyroid cancers of folliculark

cell origin that have previously been treated by thyroidectomy and radioiodine ablation

and have a serum thyroglobulin > 10ng/ml and negative I-131 whole body scan.

Contractors shall advise providers to use the appropriate CPT code from section 60.3.1

for thyroid cancer for services performed on or after January 28, 2005.

60.11 - Coverage of PET Scans for Perfusion of the Heart Using

Ammonia N-13

(Rev. 223, Issued: 07-02-04) (Effective/Implementation: Not Applicable)

Effective for service performed on or after October 1, 2003, PET scans performed at rest

or with pharmacological stress used for noninvasive imaging of the perfusion of the heart

for the diagnosis and management of patients with known or suspected coronary artery

disease using the FDA-approved radiopharmaceutical ammonia N-13 are covered,

provided the following requirements are met.